UBI Pharma Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 479.559 million compared to TWD 423.863 million a year ago. Operating loss was TWD 238.175 million compared to TWD 255.750 million a year ago. Net loss was TWD 241.880 million compared to TWD 240.966 million a year ago. Basic loss per share was TWD 1.71 compared to TWD 1.7 a year ago.